Major risk factors for cardiovascular disease - Debunking the "only 50%" myth

被引：71

作者：

Canto, JG ^{[1
]}

Iskandrian, AE ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Div Cardiovasc Dis, Chest Pain Ctr, Birmingham, AL 35294 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 290卷 / 07期

关键词：

D O I：

10.1001/jama.290.7.947

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：947 / 949

页数：3

共 29 条

[1] Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score
Albert, MA
Glynn, RJ
Ridker, PM
[J]. CIRCULATION, 2003, 108 (02) : 161 - 165
[2] *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981
[3] CARDIOVASCULAR-DISEASE RISK PROFILES
ANDERSON, KM
ODELL, PM
WILSON, PWF
KANNEL, WB
[J]. AMERICAN HEART JOURNAL, 1991, 121 (01) : 293 - 298
[4] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[5] Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale
Berg, AO
Allan, JD
Frame, PS
Homer, CJ
Johnson, MS
Klein, JD
Lieu, TA
Mulrow, CD
Orleans, CT
Peipert, JF
Pender, NJ
Siu, AL
Teutsch, SM
Westhoff, C
Woolf, SH
[J]. ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) : 157 - 160
[6] Shattuck lecture - Cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities
Braunwald, E
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) : 1360 - 1369
[7] Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein
Chew, DP
Bhatt, DL
Robbins, MA
Mukherjee, D
Roffi, M
Schneider, JP
Topol, EJ
Ellis, SG
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) : 672 - 674
[8] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian, AV
Bakris, GL
Black, HR
Cushman, WC
Green, LA
Izzo, JL
Jones, DW
Materson, BJ
Oparil, S
Wright, JT
Roccella, EJ
[J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
[9] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Cleeman, JI
Grundy, SM
Becker, D
Clark, LT
Cooper, RS
Denke, MA
Howard, WJ
Hunninghake, DB
Illingworth, DR
Luepker, RV
McBride, P
McKenney, JM
Pasternak, RC
Stone, NJ
Van Horn, L
Brewer, HB
Ernst, ND
Gordon, D
Levy, D
Rifkind, B
Rossouw, JE
Savage, P
Haffner, SM
Orloff, DG
Proschan, MA
Schwartz, JS
Sempos, CT
Shero, ST
Murray, EZ
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
[10] Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

← 1 2 3 →